Citadel Advisors »

Galmed Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Galmed Pharmaceuticals (GLMD) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Galmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Galmed Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galmed Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.1k 11k 0.46
2023-09-30 $25k 41k 0.62

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Galmed Pharmaceuticals

Walleye Trading Advisors
CVI Holdings
Two Sigma Advisers
Two Sigma Investments
Citadel Advisors
Wells Fargo & Company
TSFG
Advisor Group Holdings
Hanson McClain Advisors
Zrc Wealth Management
Bank of America Corporation

View all funds holding Galmed Pharmaceuticals